The expression of DAMP proteins HSP70 and cancer-testis antigen SPAG9 in peripheral blood of patients with HCC and lung cancer
Tóm tắt
There are different views of how the immune system participates in the reaction to cancer. Here, we evaluated expression of DAMP proteins HSP70 and cancer-testis antigen SPAG9 in patients with hepatocellular carcinoma (HCC) and lung cancer to explore tumor immunity. Our analysis showed that levels of HSP70 and SPAG9 antibody were significantly higher in the serum of lung cancer and HCC patients than in the serum of healthy subjects (P < 0.001), but there were no differences in levels of HSP70 antibody in patients and controls. Levels of serum SPAG9 antibody in newly diagnosed lung cancer patients were significantly higher than in treated lung cancer patients (P < 0.05), but there were no differences in levels of HSP70 or HSP70 antibody. Levels of serum HSP70 and SPAG9 antibody, but not HSP70 antibody, were also higher in hepatitis/cirrhosis patients than in healthy subjects (P = 0.005, P < 0.001). Levels of serum SPAG9 antibody were significantly higher in HCC patients than in hepatitis/cirrhosis patients, but there were no differences in HSP70 or HSP70 antibody levels. Finally, levels of serum HSP70 and SPAG9 antibody were significantly higher in HCC patients than in lung cancer patients (P < 0.05, P < 0.001). These results indicate that cancer-testis antigen SPAG9 induces a strong humoral immune response in cancer patients but HSP70 does not. These results show that SPAG9 has potential as a tumor-specific biomarker.
Tài liệu tham khảo
Agarwal S, Parashar D, Gupta N, et al. (2014a) Sperm associated antigen 9 (SPAG9) expression and humoral response in benign and malignant salivary gland tumors. Oncoimmunology 3(12)
Agarwal S, Parashar D, Gupta N, et al. (2014b) Sperm associated antigen 9 (SPAG9) expression and humoral response in benign and malignant salivary gland tumors. Oncoimmunology 3(12)
Alaiya AA, Oppermann M, Langridge J, Roblick U, Egevad L, Brindstedt S et al (2001) Identification of proteins in human prostate tumor material by two-dimensional gel electrophoresis and mass spectrometry. Cell Mol Life Sci 58:307–311
Bretscher P, Cohn M (1970) A theory of self-nonself discrimination. Science 169(3950):1042–1049
Burnet M (1959) The clonal selection theory of acquired immunity. Cambridge University Press, London
Chen T, Cao X (2010) Stress for maintaining memory: HSP70 as a mobile messenger for innate and adaptive immunity. Eur J Immunol 40(6):1541–1544
Garg M, Chaurasiya D, Rana R et al (2007) Sperm-associated antigen 9, a novel cancer testis antigen, is a potential target for immunotherapy in epithelial ovarian cancer. Clin Cancer Res 13(5):1421–1428
Huang B, Zhao J, Li H, He KL, Chen Y, Chen SH, Mayer L, Unkeless JC, Xiong H (2005) Toll-like receptors on tumor cells facilitate evasion of immune surveillance. Cancer Res 65(12):5009–5014
Huang B, Zhao J, Unkeless JC et al (2008) TLR signaling by tumor and immune cells: a double-edged sword. Oncogene 27(2):218–224
Jagadish N, Rana R, Selvi R et al (2005a) Molecular cloning and characterization of the macaque sperm associated antigen 9 (SPAG9): an orthologue of human SPAG9 gene. Mol Reprod Dev 71(1):58–66
Jagadish N, Rana R, Mishra D et al (2005b) Immunogenicity and contraceptive potential of recombinant human sperm associated antigen (SPAG9). J Reprod Immunol 67(1–2):69–76
Kanojia D, Garg M, Gupta S, Gupta A, Suri A (2009) Sperm-associated antigen 9, a novel biomarker for early detection of breast cancer. Cancer Epidemiol Biomark Prev 18:630–639
Kanojia D, Garg M, Saini S et al (2013) Sperm associated antigen 9 plays an important role in bladder transitional cell carcinoma. PLoS One 8(12):e81348–e81348
Kumar S, Rd SJ, Singh UP et al (2016) Targeting Hsp70: a possible therapy for cancer. Cancer Lett 374(1):156–166
Lanneau D, De TA, Maurel S et al (2007) Apoptosis versus cell differentiation: role of heat shock proteins HSP90, HSP70 and HSP27. Prion 1(1):53–60
Li H, Li Y, Liu D et al (2013) Extracellular HSP70/HSP70-PCs promote epithelial-mesenchymal transition of hepatocarcinoma cells. PLoS One 8(12):e84759
Luk JM, Lam CT, Siu AFM et al (2006) Proteomic profiling of hepatocellular carcinoma in Chinese cohort reveals heat-shock proteins (Hsp27, Hsp70, GRP78) up-regulation and their associated prognostic values. Proteomics 6(3):1049–1057
Matzinger P (1994) Tolerance, danger, and the extended family. Annu Rev Immunol 12(1):991–1045
Meng L, Hunt C, Yaglom JA et al (2011) Heat shock protein Hsp72 plays an essential role in Her2-induced mammary tumorigenesis. Oncogene 30(25):2836–2845
Miyaji EN, Carvalho E, Oliveira ML et al (2011 Jun) Trends in adjuvant development for vaccines: DAMPs and PAMPs as potential new adjuvants. Braz J Med Biol Res 44(6):500–513
Murphy ME (2013) The HSP70 family and cancer. Carcinogenesis 34(6):1181–1188
Pradeu T, Cooper EL (2012) The danger theory: 20 years later. Front Immunol 3:287–287
Radons J (2016) The human HSP70 family of chaperones: where do we stand? Cell Stress Chaperones 21(3):379–404
Ren B, Zou G, Huang Y, Xu G, Xu F, He J, Zhu H, Yu P (2016a Jul) Serum levels of HSP70 and other DAMP proteins can aid in patient diagnosis after traumatic injury. Cell Stress Chaperones 21(4):677–686
Ren B, Wei X, Zou G, He JXG, Xu F, Huang Y, Zhu H, Li Y, Ma G, Yu P (2016b May) Cancer testis antigen SPAG9 is a promising marker for the diagnosis and treatment of lung cancer. Oncol Rep 35(5):2599–2605
Sinha A, Agarwal S, Parashar D et al (2013a) Down regulation of SPAG9 reduces growth and invasive potential of triple-negative breast cancer cells: possible implications in targeted therapy. J Exp Clin Cancer Res 32(1):69–69
Sinha A, Agarwal S, Parashar D et al (2013b) Down regulation of SPAG9 reduces growth and invasive potential of triple-negative breast cancer cells: possible implications in targeted therapy. J Exp Clin Cancer Res 32(1):69–69
Song P, Gao J, Inagaki Y, Kokudo N, Hasegawa K, Sugawara Y, Tang W. Biomarkers: evaluation of screening for and early diagnosis of hepatocellular carcinoma in Japan and China. Liver Cancer .2 (1):31–39, 2013.
Srikrishna G, Freeze HH (2009) Endogenous damage-associated molecular pattern molecules at the crossroads of inflammation and cancer 1. Neoplasia 11(7):615–628
Takeda K, Akira S (2004) TLR signaling pathways. Semin Immunol 16(1):3–9
Wang Y, Dong Q, Yuan M et al (2013) Clinical significance and biological roles of SPAG9 overexpression in non-small cell lung cancer. Lung Cancer 81(2):266–272
Xie C, Fu L, Liu N et al (2014) Overexpression of SPAG9 correlates with poor prognosis and tumor progression in hepatocellular carcinoma. Tumor Biol 35(8):7685–7691
Yu P, Yan L, Zhang H et al (2012) Expression and clinical significance of sperm-associated antigen 9 in patients with endometrial carcinoma. Int J Gynecol Cancer: Off J Int Gynecol Cancer Soc 22(1):87–93